Hereditary angioedema c1-inh replacement therapy and coexisting autoimmune disorders: findings from a claims database

Hereditary angioedema (HAE) has been linked with an increase in autoimmune diseases. Plasma-derived C1 esterase inhibitor (C1-INH) is safe and effective for treatment and prevention of HAE attacks. It is plausible that C1-INH replacement decreases autoimmunity by normalizing complement.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: H. Farkas, M. Fridman, S. Krishnarajah, J. Chiao, T. Machnig, S. Prusty, M. Berger Tags: P154 Source Type: research